RSSEli Lilly and Co.
Company Information
Eli Lilly and Co. has been in business more than 132 years. The global, research-based company was founded in May 1876 by Colonel Eli Lilly in Indianapolis. A 38-year-old pharmaceutical chemist and a veteran of the U.S. Civil War, Colonel Lilly was frustrated by the poorly prepared, often ineffective medicines of his day.
Although his business flourished, Colonel Lilly wasn't satisfied with the traditional methods of testing the quality of his products. In 1886, he hired a young chemist to function as a full-time scientist, using and improving upon the newest techniques for quality evaluation.
Eventually, Colonel Lilly's son, Josiah K. Lilly Sr., and two grandsons, Eli Lilly and Josiah K. Lilly Jr., each served as president of the company.
Today Eli Lilly is the 10th largest pharmaceutical company in the world. Its global employees number approximately 40,000, and its medicines are marketed in 143 countries. Lilly has major research and development facilities in eight countries and conducts clinical trials in more than 50 countries.
Company Officers
John C. Lechleiter
Chairman, President and Chief Executive Officer
Lechleiter chairs the company’s operations committee, as well as its executive committee. Lechleiter served previously as president and chief operating officer of Lilly, beginning in 2005, when he also joined the board. In 2004, he became Lilly’s executive vice president, pharmaceutical operations. Prior to that, he had served as executive vice president for pharmaceutical products and corporate development since 2001.
Enrique Conterno
President, Lilly USA
Conterno joined Lilly as a sales representative in 1992. From 1993 to 1995, he held roles as a financial analyst, marketing associate, and business development manager. In 1996, Conterno became sales and marketing director for Lilly's Peru affiliate, and in 1998 he assumed the same role for Lilly Brazil. In 2000, Conterno was named executive director of marketing for Lilly's intercontinental region (all international markets except for Europe and Japan). In 2003, Conterno became general manager of Lilly Mexico, and in 2006 he was promoted to vice president of Lilly's neuroscience business unit in the U.S.
Frank M. Deane
President, Manufacturing
Frank M. Deane, Ph.D., was named president of manufacturing for Lilly in May 2007 and is a member of Lilly’s operations committee and the senior management council. He had been vice president of quality since December 2001.
Investor Information
For the latest financial reports, visit: http://investor.lilly.com/index.cfm
Contact Information
- Eli Lilly and Co.
- Lilly Corporate Center, 893 S. Delaware
- Indianapolis, Ind. 46285
- www.lilly.com
Featured content related to Eli Lilly and Co.
Insights from the CP 50
Videos/Podcasts
Eli Lilly News
Chemical Processing Articles That Mention Eli Lilly
Chemical Processing "Ask the Expert" From Eli Lilly
Products
Eli Lilly produces a vast list of pharmaceutical products. The company focuses its internal research efforts primarily on four core therapeutic areas: neuroscience, endocrine disorders, cancer, and cardiovascular diseases.
Solutions Centers
The Optimized Plant
Sponsored by Honeywell
Honeywell can help sustain the life of your assets and maximize the operational performance of your plant or mill.
Solutions for the Chemicals Industry
Sponsored by SAP
Measure your performance against your peers and discover which functional areas you can improve. Includes manufacturing, supply chain, R&D, regulatory compliance (ie REACH), and customer management.
Business Performance
Sponsored by Honeywell
Improve performance and increase profitability with integrated, comprehensive solutions that protect your people, process and assets, while reducing costs and improving productivity.
